While Evolent Health Inc has overperformed by 12.20%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, EVH fell by -63.20%, with highs and lows ranging from $13.61 to $3.49, whereas the simple moving average fell by -53.69% in the last 200 days.
On November 13, 2025, Stephens Upgraded Evolent Health Inc (NYSE: EVH) to Overweight. A report published by BMO Capital Markets on November 13, 2025, Initiated its previous ‘Outperform’ rating for EVH. Needham also rated EVH shares as ‘Buy’, setting a target price of $15 on the company’s shares in an initiating report dated January 10, 2025. BTIG Research Reiterated the rating as Buy on December 03, 2024, but set its price target from $36 to $29. Stephens November 08, 2024d its ‘Overweight’ rating to ‘Equal-Weight’ for EVH, as published in its report on November 08, 2024. KeyBanc Capital Markets’s report from October 11, 2024 suggests a price prediction of $35 for EVH shares, giving the stock a ‘Overweight’ rating. Truist also rated the stock as ‘Buy’.
Analysis of Evolent Health Inc (EVH)
Further, the quarter-over-quarter decrease in sales is -22.83%, showing a negative trend in the upcoming months.
In order to gain a clear picture of Evolent Health Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of -13.63% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.33, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 3.57M can be a very valuable indicator of volatility for EVH stock. On a monthly basis, the volatility of the stock is set at 9.27%, whereas on a weekly basis, it is put at 11.36%, with a loss of -0.96% over the past seven days. Furthermore, long-term investors anticipate a median target price of $11.04, showing growth from the present price of $4.14, which can serve as yet another indication of whether EVH is worth investing in or should be passed over.
How Do You Analyze Evolent Health Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 2.78%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 117.99% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
